2T. Zysset,H. Wietholtz. Differential effect of Type I and Type II diabetes on antipyrine disposition in man[J] 1988,European Journal of Clinical Pharmacology(4):369～375
3Priv.-Doz. Dr. Dr. P. Dylewicz,W. Kirch,S. R. Santos,H. J. Hutt,H. M?nig,E. E. Ohnhaus. Bioavailability and elimination of nitrendipine in liver disease[J] 1987,European Journal of Clinical Pharmacology(6):563～568
5ADNAN EI-YAZIGI, DALE A RAINES, HATIM ALI,et al. Simplified determination of antipyrine clearance by liquid chromatography of saliva or plasma [J].Pharmaceutical Research, 1991 (2) :269-272.
7Marus JL,Tabenero B,Jorquera F,Jorquera JG,Villa J,Gonzalez-Gallego.Physical exercise and improvement of liver oxidative metabolism in the elderly[J].Eur J Appl Physiol,2000;81:62-6
8Jorquera F,Almar MM.Accuracy of the one-sample method for determination antipyrine clearance in elderly subjects[J].J Pharm Biomed Anal,1996;15:7-11
9El-Yazigi A,Raines DA,Ali H,Sieck J,Ernst P,Dossing M.Simplified determination of antipyrine clearance by liquid chromatography of a microsample of saliva or plasma[J].Pharm Res,1991;2:269-72
10Janus K,Suszycka J.Effect of age on the pharmacokinetics of antipyrine in calves[J].Res Vet Sci,1996;60:234-7
